Last reviewed · How we verify
Medicine
Medicine is a Small molecule drug developed by Chinese PLA General Hospital. It is currently FDA-approved. Also known as: Other drugs, drug, SSRI antidepressants.
Medicine is the science and practice of caring for patients, managing the diagnosis, prognosis, prevention, treatment, and palliation of their injury or disease, while promoting their health. It encompasses various healthcare practices that evolved to maintain and restore health through the prevention and treatment of illness and infection, including the study of conditions such as urothelial carcinoma and the use of treatments like sitravatinib, nivolumab, and pembrolizumab.
At a glance
| Generic name | Medicine |
|---|---|
| Also known as | Other drugs, drug, SSRI antidepressants |
| Sponsor | Chinese PLA General Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Phase 1 Study of IM-1021 in Participants With Advanced Cancer (PHASE1)
- Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers (PHASE3)
- Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure) (NA)
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer (PHASE2)
- Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (PHASE1)
- Effect of Lidocaine Infusion Versus Dexmedemidine Infusion on the Neurocognitive Function of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography(ERCP): a Randomized, Controlled Trial. (NA)
- Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants (PHASE1)
- Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medicine CI brief — competitive landscape report
- Medicine updates RSS · CI watch RSS
- Chinese PLA General Hospital portfolio CI
Frequently asked questions about Medicine
What is Medicine?
Who makes Medicine?
Is Medicine also known as anything else?
What development phase is Medicine in?
Related
- Manufacturer: Chinese PLA General Hospital — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: Other drugs, drug, SSRI antidepressants
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing